Dihydroergotamine injection and Oxymorphone Extended-Release Tablets
Determining the interaction of Dihydroergotamine injection and Oxymorphone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine injection-Oxymorphone Hydrochloride
- Dihydroergotamine injection-Oxymorphone Injection
- Dihydroergotamine injection-Oxymorphone Tablets
- Dihydroergotamine injection-Oxytocin
- Dihydroergotamine injection-Oxytocin Intravenous, Intramuscular
- Dihydroergotamine injection-Oxytrol
- Oxymorphone Extended-Release Tablets-Dihydroergotamine Mesylate
- Oxymorphone Extended-Release Tablets-Dihydroergotamine nasal
- Oxymorphone Extended-Release Tablets-Dihydroergotamine Nasal Spray
- Oxymorphone Extended-Release Tablets-Dilacor XR
- Oxymorphone Extended-Release Tablets-Dilantin
- Oxymorphone Extended-Release Tablets-Dilantin Infatabs